Cerulean Pharma Inc. (Nasdaq: CERU) will eliminate 11 employees, sell some of its assets and enter a stock purchase agreement with Dare Biosciences. Shares of the cancer drug developer plummeted $2.09 to close at $1.24.
Cerulean Pharma cuts jobs, sells assets
March 20, 2017 at 17:11 PM EDT
